Jiangsu, China

Xiaobo Chen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Crown Bioscience (Suzhou) Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaobo Chen. Retrieved from https://idiyas.com/inventor/xiaobo-chen-t74j4nq1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaobo Chen and His Work in Tumor Immunology

Introduction

Xiaobo Chen is an inventor associated with Jiangsu, China, and Crown Bioscience (Suzhou) Inc. His patent work concerns methods for assessing immune responses in murine tumor models.

Latest Patents

Chen is listed as an inventor on 1 patent: “Methods and Compositions for Assessing Immune Response in Murine Tumor Models.” The disclosure describes methods and compositions, including kits and microarrays, for assessing immune responses in murine tumor models through the expression of a gene panel that characterizes interactions between tumors and the immune system.

Career Highlights

Chen’s listed patent reflects work at the intersection of tumor research and immune-response assessment. The disclosed approaches are designed to help characterize tumor–immune interactions in murine models.

Collaborations

The provided information lists Jia Xue and Sheng Guo as Chen’s coworkers at Crown Bioscience (Suzhou) Inc. They are not identified here as co-inventors on the patent.

Conclusion

Xiaobo Chen’s patent contribution focuses on tools for evaluating immune responses in murine tumor models, linking gene-expression analysis with the study of tumor–immune interactions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…